Reference Centre For Rare News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Reference Centre For Rare. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Reference Centre For Rare Today - Breaking & Trending Today

BrainVectis, a subsidiary of AskBio, receives clearance to conduct Phase I/II clinical trial in France for its novel gene therapy for early-stage Huntington's Disease

Published: August 23, 2022

/PRNewswire/ -- Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, has received clearance to conduct...

Source: prnewswire.com

Related Topics:

France GeneralNorth CarolinaUnited StatesUnited KingdomResearch Triangle ParkCity OfAlexandra DurrSheila MikhailNathalie Cartier LacaveBayer AgReference Centre For RareNational Agency For Safety Of MedicinesHealth ProductsCommittee For Orphan Medicinal ProductsEuropean UnionEthics CommitteePrnewswire Asklepios Biopharmaceutical IncEuropean Medicines AgencyAsklepios Biopharmaceutical IncFrench Ethics CommitteeNational AgencyEuropean MedicinesVice PresidentSector Lead NeurobiologyOrphan Medicinal Products